Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

Linda McMaken has 15+ years of experience as a writer and editor. She is a published author and skilled blogger about consumer finance. Ryan Eichler holds a B.S.B.A with a concentration in Finance ...

Mitchell Grant is a self-taught investor with over 5 years of experience as a financial trader. He is a financial content strategist and creative content editor. Dr. JeFreda R. Brown is a financial ...